Rock Springs Capital Management »

Bicara Therapeutics shares owned by Rock Springs Capital Management

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Rock Springs Capital Management from 13F filings

Historical chart of Rock Springs Capital Management investment in Bicara Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 298M9M10M11M445.974k445.9745k445.975k445.9755k445.976k
Value ($)Share countHistorical BCAX position of Rock Springs Capital … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Rock Springs Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.8M 446k 17.42
2024-09-30 $11M 446k 25.47

More positions owned by Rock Springs Capital Management

Argenx Se Sponsored Adr (ARGX)
Intuitive Surgical Com New (ISRG)
Eli Lilly & Co. (LLY)
Neurocrine Biosciences (NBIX)
Blueprint Medicines (BPMC)
UnitedHealth (UNH)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Ultragenyx Pharmaceutical (RARE)
Rhythm Pharmaceuticals (RYTM)
Mirum Pharmaceuticals (MIRM)
Alnylam Pharmaceuticals (ALNY)
Penumbra (PEN)
West Pharmaceutical Services (WST)
Revolution Medicines (RVMD)

View all positions for Rock Springs Capital Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Omega Fund Management
Adage Capital Partners GP
FMR
Braidwell
Deerfield Management Company
T. Rowe Price Associates
Fairmount Funds Management
BlackRock
Vanguard Group
Fil
Blackstone Group
Henderson Group

View all funds holding Bicara Therapeutics